X

Health Kick Podcast: Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray

share

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment of The Health Kick Podcast.

In this episode Tim chats with Dr Jackie Fairley, CEO of Starpharma Holdings Limited (ASX: SPL, OTCQX:SPHRY)

Starpharma is a Melbourn-based ASX 300 company and a leader in the development of dendrimer products for pharmaceutical, life science and other applications.

The company’s underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses.

To hear more about the company, it’s impressive share price run in 2020 and plans for the year ahead, click below.

On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.

Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!

Categories: Health & Biotech

share

Related Posts